A few days ago, two to be exact, I posted what my portfolio would look like if I had kept all the stocks I owned in 2006. I would have been making 303% on one of the stocks, Denderon (DNDN). This morning that stock dropped 60% on news that the FDA is delaying any chances of approval for their prostate cancer drug Provenge. Here’s what my portfolio would look like today:

The lesson: don’t place all your eggs in one basket.